Browsing NTU Scholars | NTU Scholars

Showing results 1 to 20 of 44 next >

Issue Date	Title	Author(s)	Source	scopus	WOS
2014	Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy	Lu L.-C.; YU-YUN SHAO ; Chan S.-Y.; Hsu C.-H.; Cheng A.-L.	Anticancer Research	7	6
2014	Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy	Lu L.-C.; Shao Y.-Y.; Chan S.-Y.; CHIH-HUNG HSU ; Cheng A.-L.	Anticancer Research	7	6
2019	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; YU-YUN SHAO ; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.	Expert Review of Gastroenterology and Hepatology	0	1
2019	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; CHIH-HUNG HSU ; Cheng A.-L.	Expert Review of Gastroenterology and Hepatology	0	1
2019	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Chiun Hsu ; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.	Expert Review of Gastroenterology and Hepatology	0	1
2019	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; YU-YUN SHAO ; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.	Liver Cancer	2	6
2019	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; CHIH-HUNG HSU ; Cheng A.-L.	Liver Cancer	2	6
2019	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH ; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.	Liver Cancer	2	6
2019	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	YU-YUN SHAO ; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.	Liver International	1	1
2019	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; CHIH-HUNG HSU	Liver International	1	1
2013	Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma	Lu L.-C.; YU-YUN SHAO ; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.	Cancer	8	8
2013	Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma	Lu L.-C.; Shao Y.-Y.; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; CHIH-HUNG HSU ; Cheng A.-L.; Lai M.-S.	Cancer	8	8
2019	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; CHIH-HUNG HSU	Liver Cancer	10	12
2019	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; YU-YUN SHAO ; Liu T.-H.; Cheng A.-L.; Hsu C.-H.	Liver Cancer	10	12
2019	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; CHIA-TUNG SHUN ; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.	Liver Cancer	10	12
2011	Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy	YU-YUN SHAO ; Lu L.-C.; Cheng A.-L.; Hsu C.-H.	Oncologist	27	25
2011	Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy	Shao Y.-Y.; Lu L.-C.; Cheng A.-L.; CHIH-HUNG HSU	Oncologist	27	25
2016	Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma	Lin H.-H.; Feng W.-C.; Lu L.-C.; YU-YUN SHAO ; Hsu C.-H.; Cheng A.-L.	Cancer Letters	22	25
2016	Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma	Lin H.-H.; Feng W.-C.; Lu L.-C.; Shao Y.-Y.; CHIH-HUNG HSU ; Cheng A.-L.	Cancer Letters	22	25
2012	Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer	Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; WEN-FANG CHENG ; Lin Y.-L.; Cheng A.-L.; Yeh K.-H.	Anticancer Research	0

Showing results 1 to 20 of 44 next >

DSpace CRIS

Browsing by Author Lu L.-C.